Articles: sars-cov-2.
-
Work-related musculoskeletal (MSK) injuries pose significant challenges to workers' health, productivity, and healthcare systems. Increased working from home since the onset of the COVID-19 pandemic may have affected the incidence and prevalence of work-related MSK injuries. Despite workers' compensation systems providing valuable data, underreporting remains a concern, necessitating additional data sources such as hospital admissions to better understand the burden of MSK injuries. ⋯ The study observed a gradual decrease in the overall incidence rate of hospital admissions for cumulative work-related MSK injuries over the last decade. Despite expectations of disruptions, no significant deviations in MSK injury trends were observed following the onset of the COVID-19 pandemic in Victoria, Australia.
-
Journal of critical care · Feb 2025
Shock prediction with dipeptidyl peptidase-3 and renin (SPiDeR) in hypoxemic patients with COVID-19.
Plasma dipeptidyl peptidase-3 (DPP3) and renin levels are associated with organ dysfunction and mortality. However, whether these biomarkers are associated with the subsequent onset of shock in at-risk patients is unknown. ⋯ In patients hospitalized with COVID-19 and hypoxemia without baseline hypotension, higher baseline plasma levels of DPP3 but not renin were associated with increased risk of subsequent shock and death.
-
The SARS-CoV-2 virus, responsible for COVID-19, has the potential to induce the formation of antibodies that target self-antigens. This study aimed to investigate the prevalence of antinuclear antibodies (ANA), the most common type of autoantibody, in both healthy individuals and those recovered from COVID-19. ⋯ One in every two to three individuals with COVID-19 exhibited ANA positivity, indicating that the SARS-CoV-2 virus poses a significant risk regarding autoimmunity. Furthermore, the incidence of ANA in healthy individuals was observed to be higher than the literature average.
-
Observational Study
Assessing the impact of comorbidities on disease severity in COVID-19 patients requires consideration of age.
Older age and comorbidities are risk factors for increased coronavirus disease 2019 (COVID-19) severity, but few studies have explored their interaction. This study aimed to assess the actual impacts of these factors on disease severity in COVID-19. The enrolled COVID-19 patients were divided into 4 age subgroups (≤44, 45-59, 60-74, and ≥75 years). ⋯ When comorbidities alone were used to predict disease severity, only the predictions were consistent with real outcomes in patients aged ≥75 years, compared with the predictions of high-risk comorbidities mentioned in World Health Organization and Chinese guidelines (Kappa 0.106, P < .05). Although older age and comorbidities were risk factors for severe COVID-19, their effects on disease severity varied across age groups. Additionally, comorbidities had a greater impact on COVID-19 severity in younger patients.